Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis

References

• Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000; 97:2163 - 7; http://dx.doi.org/10.1073/pnas.040565397; PMID: 10681462
   PubMed Web of Science ®Google Scholar
• Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, et al. Endotoxin-tolerant mice have mutations in toll-like receptor 4 (TLR4). J Exp Med 1999; 189:615 - 25; http://dx.doi.org/10.1084/jem.189.4.615; PMID: 9989976
   PubMed Web of Science ®Google Scholar
• Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and Lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 1999; 274:17406 - 9; http://dx.doi.org/10.1074/jbc.274.25.17406; PMID: 10364168
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Brandenburg K, Kusumoto S, Fukase K, Mackie A, Seydel U, et al. Combinational clustering of receptors following stimulation by bacterial products determines LPS responses. Biochem J 2004; 381:527 - 36; http://dx.doi.org/10.1042/BJ20040172; PMID: 15040785
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Lepper PM, Briault CD, Ahmed AM, Dmochowski JM, Schumann C, et al. Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide “sensing apparatus”. Eur J Immunol 2008; 38:192 - 203; http://dx.doi.org/10.1002/eji.200636821; PMID: 18081034
   PubMed Web of Science ®Google Scholar
• Ulevitch RJ, Johnston AR. The modification of biophysical and endotoxin properties of bacterial lipopolysaccharides by serum. J Clin Invest 1978; 62:1313 - 24; http://dx.doi.org/10.1172/JCI109252; PMID: 372234
   PubMed Web of Science ®Google Scholar
• Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986; 83:2704 - 8; http://dx.doi.org/10.1073/pnas.83.8.2704; PMID: 3517876
   PubMed Web of Science ®Google Scholar
• Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86:696 - 702; http://dx.doi.org/10.1172/JCI114765; PMID: 2394827
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Mentel C, Lu L, Morrison DC, Broxmeyer HE. Lactoferrin-lipopolysaccharide interactions. J Immunol 1991; 146:723 - 9; PMID: 1702815
   PubMed Web of Science ®Google Scholar
• Fletcher J. The effect of iron and transferrin on the killing of Escherichia coli in fresh medium. Immunology 1971; 20:493 - 500; PMID: 4994865
   PubMed Web of Science ®Google Scholar
• Berger D, Berger H. Quantitation of the endotoxin-binding capacity of human transferrin. Bact Endotoxins 1988;115-124.
   Google Scholar
• Roth RI, Kaca W, Levin J. Hemoglobin, a newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res 1994; 388:161 - 72; PMID: 7831356
   PubMedGoogle Scholar
• Roth R, Kaca W. Toxicity of haemoglobin solutions: Haemoglobin is a lipopolysaccharide (LPS) binding protein which enhances LPS biological activity. Art Cells. Blood Subs and Immob Biotech 1994; 22:387 - 98; http://dx.doi.org/10.3109/10731199409117869
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, Feingold KR. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res 1999; 40:245 - 52; PMID: 9925653
   PubMed Web of Science ®Google Scholar
• Munford RS, Hall CL, Dietschy JM. Binding of Salmonella typhimurium lipopolysaccharide to rat high-density lipoproteins. Infect Immun 1981; 34:835 - 43; PMID: 7037642
   PubMed Web of Science ®Google Scholar
• Ulevitch RJ, Johnston AR, Meinstein DB. New function of high density lipoproteins. J Clin Invest 1981; 67:827 - 37; http://dx.doi.org/10.1172/JCI110100; PMID: 7204557
   PubMed Web of Science ®Google Scholar
• Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 1999; 274:34116 - 22; http://dx.doi.org/10.1074/jbc.274.48.34116; PMID: 10567381
   PubMed Web of Science ®Google Scholar
• Sprong T, Netea MG, van der Ley PT, Verver-Jansen TJG, Jacobs LEH, Stalenhoef A, et al. Human lipoproteins have divergent neutralizing effects on E.Coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria. J Lipid Res 2004; 45:742 - 9; http://dx.doi.org/10.1194/jlr.M300453-JLR200; PMID: 14754910
   PubMed Web of Science ®Google Scholar
• Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001; 29:1563 - 8; http://dx.doi.org/10.1097/00003246-200108000-00011; PMID: 11505128
   PubMed Web of Science ®Google Scholar
• Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, et al. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology 2007; 46:1893 - 906; http://dx.doi.org/10.1002/hep.21875; PMID: 17918268
   PubMed Web of Science ®Google Scholar
• Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced cytokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 1993; 61:5140 - 6; PMID: 8225591
   PubMed Web of Science ®Google Scholar
• Hubsch AP, Powell FS, Lerch PG, Doran JE. A reconstituted, apolipoprotein A-1 containing lipoprotein reduces tumour necrosis factor release and attenuates shock in endotoxemic rabbits. Circ Shock 1993; 40:14 - 23; PMID: 8324886
   PubMedGoogle Scholar
• de Bont N, Netea MG, Demacker PNM, Verschueren I, Kullberg BJ, Van Dijk KW, et al. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999; 40:680 - 5; PMID: 10191292
   PubMed Web of Science ®Google Scholar
• Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, et al. Human Apolipoprotein A-IV reduces secretion of pro-inflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler Thromb Vasc Biol 2004; 24:756 - 61; http://dx.doi.org/10.1161/01.ATV.0000119353.03690.22; PMID: 14751811
   PubMed Web of Science ®Google Scholar
• Berbée JF, Havekes LM, Rensen PC. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 2005; 11:97 - 103; PMID: 15949136
   PubMedGoogle Scholar
• de Haas CJC, van Leeuwen HJ, Verhoef J, van Kessel KPM, van Strijp JAP. Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labelled LPS. J Immunol Methods 2000; 242:79 - 89; http://dx.doi.org/10.1016/S0022-1759(00)00207-6; PMID: 10986391
   PubMed Web of Science ®Google Scholar
• Dziarski R. Cell bound albumin is the 70 kDa peptidoglycan-, lipopolysaccharide, and lipoteichoic acid -binding protein on lymphocytes and macrophages. J Biol Chem 1994; 269:20431 - 6; PMID: 8051139
   PubMed Web of Science ®Google Scholar
• Mueller M, Stamme C, Draing C, Hartung T, Seydel U, Schromm AB. Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein. J Biol Chem 2006; 281:31448 - 56; http://dx.doi.org/10.1074/jbc.M605966200; PMID: 16928689
   PubMed Web of Science ®Google Scholar
• Manthey CL, Vogel SN. Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res 1994; 1:84 - 90
   Google Scholar
• Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. Toll-like receptor 4, but not toll-like receptor 2, is a signalling receptor for Escherichia and Salmonella Lipopolysaccharides. J Immunol 2000; 165:5780 - 7; PMID: 11067937
   PubMed Web of Science ®Google Scholar
• Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Repurification of lipopolysaccharide eliminates signalling through both human and murine toll-like receptor 2. J Immunol 2000; 165:618 - 22; PMID: 10878331
   PubMed Web of Science ®Google Scholar
• Morath S, Geyer A, Spreitzer I, Hermann C, Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect Immun 2002; 70:938 - 44; http://dx.doi.org/10.1128/IAI.70.2.938-944.2002; PMID: 11796629
   PubMed Web of Science ®Google Scholar
• Troelstra A, Antal-Szalmas P, De Graaf-Miltenburg LA, Weersink AJ, Verhoef J, Van kessel KP, et al. Saturable CD14-dependent binding of fluorescein-labelled lipopolysaccharide to human monocytes. Infect Immun 1997; 65:2272 - 7; PMID: 9169763
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Triantafilou K, Fernandez N. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influenced by endotoxin concentartion. Eur J Biochem 2000; 267:2218 - 26; http://dx.doi.org/10.1046/j.1432-1327.2000.01222.x; PMID: 10759844
   PubMedGoogle Scholar
• Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250 - 6; http://dx.doi.org/10.1097/01.CCM.0000050454.01978.3B; PMID: 12682500
   PubMed Web of Science ®Google Scholar
• Triantafilou K, Triantafilou M, Dedrick RLA. CD14-independent LPS receptor cluster. Nat Immunol 2001; 2:338 - 45; http://dx.doi.org/10.1038/86342; PMID: 11276205
   PubMed Web of Science ®Google Scholar